|
| | | Item | | (%) |
|
| Number 1 | Title | The words “case report” | 93/93 | 100.0 |
| Number 2 | Keywords | Key elements | 93/93 | 100.0 |
| Number 3 | Abstract | Introduction: what does this add? | 93/93 | 100.0 |
| Number 4 | | Case presentation: main symptoms | 47/93 | 50.5 |
| Number 5 | | Case presentation: main clinical findings | 91/93 | 97.8 |
| Number 6 | | Case presentation: main diagnoses and interventions | 93/93 | 100.0 |
| Number 7 | | Case presentation: main outcomes | 93/93 | 100.0 |
| Number 8 | | Conclusion: main “take-away” lessons | 93/93 | 100.0 |
| Number 9 | Introduction | Brief background summary of this case | 93/93 | 100.0 |
| Number 10 | Patient information | Demographic information | 93/93 | 100.0 |
| Number 11 | | Main symptoms of the patient | 93/93 | 100.0 |
| Number 12 | | Medical, family, and psychosocial history | 92/93 | 98.9 |
| Number 13 | Clinical findings | Physical examination findings | 93/93 | 100.0 |
| Number 14 | Timeline | Depicts important dates and times | 77/93 | 82.8 |
| Number 15 | Diagnostic assessment | Diagnostic methods | 83/93 | 89.2 |
| Number 16 | | Diagnostic challenges | 2/93 | |
| Number 17 | | Diagnostic reasoning including other diagnoses considered | 12/93 | |
| Number 18 | | Prognostic characteristics | 24/93 | |
| Number 19 | Therapeutic intervention | Type of intervention (e.g., pharmacologic, surgical, preventive) | 93/93 | 100.0 |
| Number 20 | | Administration of intervention (e.g., dosage, strength, duration) | 93/93 | 100.0 |
| Number 21 | | Changes in intervention (with rationale) | 24/93 | |
| Number 22 | Follow-up and outcomes | Clinician and patient-assessed outcomes | 93/93 | 100.0 |
| Number 23 | | Important follow-up test results | 93/93 | 100.0 |
| Number 24 | | Intervention adherence and tolerability | 0/93 | |
| Number 25 | | Adverse and unanticipated events | 15/93 | |
| Number 26 | Discussion | Strengths and limitations of the management of this case | 93/93 | 100.0 |
| Number 27 | | The relevant medical literature | 93/93 | 100.0 |
| Number 28 | | The rationale for conclusions (assessments of cause and effect) | 93/93 | 100.0 |
| Number 29 | | The main “take-away” message | 93/93 | 100.0 |
| Number 30 | Patient perspective | Patient perspective or experience | 27/93 | |
| Number 31 | Informed consent | Informed consent | 12/93 | |
|
| | | Average | 70.3/93 | 75.4 |
| | | CARE index: mean (95% CI) | 75.4 (74.4 to 76.4) |
|
